Apricus Biosciences' Wholly-Owned Subsidiary NexMed(U.S.A.) and Takeda Pharmaceuticals International GmbH Sign Exclusive License Agreement to Market Vitaros(R) in the United Kingdom

2012.09.13 20:28:34

[By NBC-1TV H. J Yook]Apricus Biosciences, Inc. (Nasdaq:APRI) and Takeda Pharmaceuticals International GmbH jointly announced today that they have entered into an exclusive license agreement to market Vitaros®, a treatment for erectile dysfunction, in the UK.

Under the terms of the agreement, Takeda will pay NexMed (U.S.A.), a wholly owned subsidiary of Apricus Biosciences, an undisclosed upfront payment, and milestone payments of up to €35 million. According to IMS Health, the erectile dysfunction market in the United Kingdom was worth approximately €202 million in 2011.

Dr. Bassam Damaj, President and Chief Executive Officer of Apricus Bio commented, “We look forward to expanding the reach of our Vitaros® product for erectile dysfunction in the UK, the second largest ED market in Europe. Takeda is a research-based global pharmaceutical company and a well-known and trusted name in the industry. This partnership further demonstrates our commitment to our commercialization strategy to make Vitaros® available to patients worldwide.”

“This is a great opportunity for Takeda UK,” said Yasuhiro Fukutomi, Managing Director, Takeda UK. “Takeda is committed to providing novel and innovative treatments that make a real difference to patients' lives. Vitaros® is an innovative new product that offers the potential to provide men with a new first line or alternative treatment option. Vitaros® has been shown in clinical trials to provide rapid, on-demand efficacy together with convenient local administration that is well tolerated.1,2 Takeda UK envisages that Vitaros® will be a significant addition to our urology franchise.”


By H. J Yook hjyook@nbc1tv.com
< 저작권자 © NBC-1TV , 무단전재 및 재배포금지 >







PC버전으로 보기


주소 : 서울특별시 영등포구 여의도동 17-20번지 원정빌딩 4층(KBS 본관 옆)
Add : Rm. 401 Won-Jeong Building, #17-20. Yoido-Dong, Youngdeungpo
-Gu, Seoul, Korea | Tel : 82-2-6414-6114 | Fax : 82-2-761-3114 |
대표전화 : 02-6414-6114 | 팩스 : 02-761-3114 | 보도국 당직 : 010-3329-6114
E-mail : korea@nbc1tv.com | seoul@nbc1tv.com
Copyright ⓒ 2007 NBC-1TV News Beyond Cliche All rights reserved.